Expanding the Target Landscape by Drugging the Undruggable
Funds early-stage work to find a method or agent that hits a human disease target considered undruggable.
Most drug discovery targets proteins that are already known to be reachable — a pocket a small molecule can bind, a receptor with a known ligand. This notice funds the harder problem: targets nobody has found a way to drug yet.
The ask has two parts, and both are required. Identify a human-disease-relevant target class that counts as undruggable. Then develop a method or agent that is selective f…
Early-stage, exploratory identification of a human-disease-relevant undruggable target class and development of a method or agent selective for one or more targets within it, moving beyond established therapeutic types. A clinical trial is not allowed.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up